Andrei A. Savchenko, Igor V. Kudryavtsev, Dmitry V. Isakov, Ivan S. Sadowski, Vasily D. Belenyuk, & Alexandr G. Borisov. (2023). Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome. MDPI AG.
Chicago Style (17th ed.) CitationAndrei A. Savchenko, Igor V. Kudryavtsev, Dmitry V. Isakov, Ivan S. Sadowski, Vasily D. Belenyuk, and Alexandr G. Borisov. Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome. MDPI AG, 2023.
MLA (9th ed.) CitationAndrei A. Savchenko, et al. Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.